Federation des caisses Desjardins du Quebec’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12	Closed	-$60	–	2607
2024 Q1	$60	Hold	12	–	–	﹤0.01%	2350
2023 Q4	$83	Hold	12	–	–	﹤0.01%	2306
2023 Q3	$113	Hold	12	–	–	﹤0.01%	2305
2023 Q2	$260	Hold	12	–	–	﹤0.01%	2231
2023 Q1	$332	Hold	12	–	–	﹤0.01%	2236
2022 Q4	$437	Hold	12	–	–	﹤0.01%	2363
2022 Q3	$2.79K	Hold	12	–	–	﹤0.01%	2204
2022 Q2	$2.33K	Hold	12	–	–	﹤0.01%	2286
2022 Q1	$3.07K	Hold	12	–	–	﹤0.01%	2300
2021 Q4	$1.92K	Hold	12	–	–	﹤0.01%	2364
2021 Q3	$2.47K	Hold	12	–	–	﹤0.01%	2383
2021 Q2	$3.15K	Hold	12	–	–	﹤0.01%	2344
2021 Q1	$3.27K	Hold	12	–	–	﹤0.01%	2278
2020 Q4	$4.55K	Hold	12	–	–	﹤0.01%	2100
2020 Q3	$3.01K	Hold	12	–	–	﹤0.01%	1966
2020 Q2	$3.55K	Hold	12	–	–	﹤0.01%	1863
2020 Q1	$2.52K	Hold	12	–	–	﹤0.01%	1962
2019 Q4	$5.51K	Hold	12	–	–	﹤0.01%	2007
2019 Q3	$3.79K	Buy	+12	New	+$3.9K	﹤0.01%	2014

Other funds holding EIGR

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's EIGR Position: Q2 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2024, closing a stake of 12 shares — an estimated $60 sold.

Federation des caisses Desjardins du Quebec first reported a position in EIGR in Q3 2019 and held it in 19 quarters. The position peaked at $5.51K in Q4 2019. 2 funds tracked by Wall St. Rank hold EIGR as of Q2 2024.

Federation des caisses Desjardins du Quebec reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 12 Eiger BioPharmaceuticals, Inc. shares in Q2 2024, an estimated $60.
Federation des caisses Desjardins du Quebec first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2019 and held it in 19 quarters.
Federation des caisses Desjardins du Quebec's Eiger BioPharmaceuticals, Inc. position peaked at $5.51K in Q4 2019.
2 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2024, filed 14 Aug 2024.